"Heart conditions continue despite new demands on our healthcare system due to the COVID-19 virus. MUSC Health cardiologists and cardiac specialists are committed to providing safe access to nationally recognized care to you and your family during this unprecedented time. Through our virtual care network you are able to connect directly with our care team members who can help with diagnosis and treatment. Select appointments available, please call to schedule a virtual visit."

During the past decade, MUSC Health East Cooper conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "MUSC Health East Cooper" #1 collaborator was "Canadian Cancer Trials Group (CCTG)" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "MUSC Health East Cooper" are "Advanced Cancer" (1 trials), "Breast Screening" (1 trials), "Metastatic Pancreatic Ductal Adenocarcinoma" (1 trials) and "Neoplasm" (1 trials). Many other conditions were trialed in "MUSC Health East Cooper" in a lesser frequency.

Most popular intervention types in "MUSC Health East Cooper" are "Drug" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin" (1 trials), "Dacomitinib" (1 trials), "Digital Mammography" (1 trials), "Digital Tomosynthesis Mammography" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "MUSC Health East Cooper" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "MUSC Health East Cooper". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MUSC Health East Cooper, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in MUSC Health East Cooper, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".